In this edition of MST Access In the Spotlight, we sat down with Merrill Gray, CEO and Managing Director of AnteoTech Ltd Limited (ADO.ASX), to discuss the company’s opportunity across two high-growth markets: advanced batteries and life sciences.

Merrill Gray discusses the evolution of AnteoTech Ltd’s proprietary chemical platform and how it is being applied across next-generation battery technologies, including Ultranode 95 for high-silicon anodes and emerging opportunities in applications such as military drones.

Within life sciences, AnteoTech Ltd’s technology is being leveraged to enhance diagnostic performance and support more efficient vaccine development, with the company expanding its commercial reach across key markets in Asia and the US.

With two distinct growth pathways and increasing global engagement, AnteoTech Ltd is entering an important phase of commercialisation, with progress across its key initiatives expected to be central to its future growth trajectory.

Watch the full interview here: https://lnkd.in/gV6qP926

Read our latest research here: https://lnkd.in/g_xs7gA2

Further reports available here: https://lnkd.in/gkimh9_B

If you don’t have an existing MST Access account, register here: https://lnkd.in/g-jxNPcH

This general advice has been prepared by MST Access and receives fees payable by Anteotech Ltd (ADO.AX) for ongoing coverage. Within the past 12 months, MST and its associates have received compensation for investment banking services provided to ADO.AX, including acting as Joint Lead Manager for the February 2026 capital raising of approximately A$3.5 million and as Option Underwriter for the June 2026 capital raising of approximately A$7.5 million.

Please see our full Disclosures and Financial Services Guide at mstfinancial.com.au

hashtag#MSTAccess hashtag#AnteoTech hashtag#ADO hashtag#ASX hashtag#AdvancedMaterials hashtag#BatteryTechnology hashtag#LifeSciences hashtag#Technology

https://www.linkedin.com/feed/update/urn:li:activity:7482647811663228929